Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Baylis Hillman Reaction. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102120749A reveals a novel organocatalyst achieving 99% ee in intramolecular Baylis-Hillman reactions, offering a metal-free route for complex API intermediates.
Patent CN105367434A details isobutyraldehyde route for pregabalin. Ensures high purity and supply chain stability for global pharmaceutical manufacturing needs.
Patent CN106146306A reveals a metal-free organocatalytic route for axial chiral biaryl compounds, offering significant cost reduction and supply chain reliability for fine chemical manufacturing.
Novel patent CN103467287B offers efficient synthesis for Vitamin A intermediates. Achieve cost reduction and supply chain reliability with high-purity pharmaceutical intermediates.